Delivery Order SPE2DX22D0010-SPE2D826FCD04
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,516.09 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on June 27, 2025, with an ultimate completion date of June 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for Metadate CD Caps 30mg, a methylphenidate-based attention deficit hyperactivity disorder medication. This firm fixed-price delivery order, valued at $6,920.67, is set to be completed by September 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,784.33 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitive award, issued on May 30, 2025, represents a firm fixed-price delivery order with a completion deadline of June 2, 2025. The contract carries no small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Medical Supply Chain has awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This non-set-aside competitive award, issued on September 4, 2025, carries a ceiling value of $3,447.55 and is scheduled for completion by September 5, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $16,551.16, represents a non-competitive set-aside award and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $5,591.54 delivery order for Metadate CD Caps 30mg, a prescription stimulant medication used in the treatment of attention deficit hyperactivity disorder. The contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,666.38 to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate extended-release medication used to treat attention deficit hyperactivity disorder. This firm fixed-price, competitively awarded contract was issued on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for Metadate CD Caps 10mg, a methylphenidate-based medication used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,890.98 and is scheduled for ultimate completion by September 12, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for $6,584.61 to deliver Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 6, 2025, for the supply of Metadate CD Caps 10mg, a medication used to treat attention-deficit/hyperactivity disorder. This is a firm fixed-price delivery order with a ceiling value of $3,203.63 and an ultimate completion date of October 7, 2025. The award is unclassified as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCD04Delivery Order
The Defense Department's Medical Supply Chain awarded a $2,879.62 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 10mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. The award, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, was made on a firm fixed-price basis without set-aside designation, indicating competitive award to this established federal pharmaceutical vendor. AmerisourceBergen's Corporate Office division in Conshohocken, Pennsylvania will serve as the place of performance for this delivery order. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally in support of military healthcare programs. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its existing $1 billion IDC platform, positions it as a critical pharmaceutical distributor for Defense Department medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/1/26 |